Meloxicam complexation with beta-cyclodextrin: influence on the anti-inflammatory and ulcerogenic activity.
Baboota
S
S
Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi, India. sbaboota@rediffmail.com
Agarwal
S P
SP
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000737:chemistry / Q000494:pharmacology*; D003505:Cyclodextrins / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D004487:Edema / Q000188:drug therapy / Q000473:pathology; D007413:Intestinal Mucosa / Q000473:pathology; D008297:Male; D000077239:Meloxicam; D051381:Rats; D017208:Rats, Wistar; D013276:Stomach Ulcer / Q000139:chemically induced*; D013843:Thiazines / Q000009:adverse effects* / Q000737:chemistry / Q000494:pharmacology*; D013844:Thiazoles / Q000009:adverse effects* / Q000737:chemistry / Q000494:pharmacology*; D047392:beta-Cyclodextrins
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003505:Cyclodextrins; D013843:Thiazines; D013844:Thiazoles; D047392:beta-Cyclodextrins; C031215:betadex; D000077239:Meloxicam